These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 20338746

  • 1. Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98.
    McDowell HP, Foot AB, Ellershaw C, Machin D, Giraud C, Bergeron C.
    Eur J Cancer; 2010 Jun; 46(9):1588-95. PubMed ID: 20338746
    [Abstract] [Full Text] [Related]

  • 2. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
    Stevens MC, Rey A, Bouvet N, Ellershaw C, Flamant F, Habrand JL, Marsden HB, Martelli H, Sanchez de Toledo J, Spicer RD, Spooner D, Terrier-Lacombe MJ, van Unnik A, Oberlin O.
    J Clin Oncol; 2005 Apr 20; 23(12):2618-28. PubMed ID: 15728225
    [Abstract] [Full Text] [Related]

  • 3. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, Tridello G, Garaventa A, Pinkerton R, Stevens M.
    J Clin Oncol; 2004 Dec 01; 22(23):4787-94. PubMed ID: 15570080
    [Abstract] [Full Text] [Related]

  • 4. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
    Orbach D, Rey A, Oberlin O, Sanchez de Toledo J, Terrier-Lacombe MJ, van Unnik A, Quintana E, Stevens MC.
    J Clin Oncol; 2005 Jul 01; 23(19):4363-71. PubMed ID: 15994146
    [Abstract] [Full Text] [Related]

  • 5. Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma.
    Bisogno G, Ferrari A, Prete A, Messina C, Basso E, Cecchetto G, Indolfi P, Scarzello G, D'Angelo P, De Sio L, Di Cataldo A, Carli M.
    Eur J Cancer; 2009 Nov 01; 45(17):3035-41. PubMed ID: 19783136
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.
    Walterhouse DO, Lyden ER, Breitfeld PP, Qualman SJ, Wharam MD, Meyer WH.
    J Clin Oncol; 2004 Apr 15; 22(8):1398-403. PubMed ID: 15007087
    [Abstract] [Full Text] [Related]

  • 7. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C, Zoubek A, Ladenstein R, van den Berg H, Hunold A, Cassoni A, Spooner D, Grimer R, Whelan J, McTiernan A, Jürgens H, European Intergroup Cooperative Ewing's Sarcoma Study-92.
    J Clin Oncol; 2008 Sep 20; 26(27):4385-93. PubMed ID: 18802150
    [Abstract] [Full Text] [Related]

  • 8. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
    Réguerre Y, Martelli H, Rey A, Rogers T, Gaze M, Ben Arush MW, Devalck C, Oberlin O, Stevens M, Orbach D.
    Eur J Cancer; 2012 Sep 20; 48(13):2020-7. PubMed ID: 22154650
    [Abstract] [Full Text] [Related]

  • 9. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
    Dantonello TM, Int-Veen C, Harms D, Leuschner I, Schmidt BF, Herbst M, Juergens H, Scheel-Walter HG, Bielack SS, Klingebiel T, Dickerhoff R, Kirsch S, Brecht I, Schmelzle R, Greulich M, Gadner H, Greiner J, Marky I, Treuner J, Koscielniak E.
    J Clin Oncol; 2009 Mar 20; 27(9):1446-55. PubMed ID: 19224858
    [Abstract] [Full Text] [Related]

  • 10. Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.
    Kojima Y, Hashimoto K, Ando M, Yonemori K, Yamamoto H, Kodaira M, Yunokawa M, Shimizu C, Tamura K, Hosono A, Makimoto A, Fujiwara Y.
    Cancer Chemother Pharmacol; 2012 Sep 20; 70(3):391-7. PubMed ID: 22806306
    [Abstract] [Full Text] [Related]

  • 11. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL, Anderson J, Pappo AS, Meyer WH, Children's Oncology Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3844-51. PubMed ID: 16921036
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study).
    Oberlin O, Deley MC, Bui BN, Gentet JC, Philip T, Terrier P, Carrie C, Mechinaud F, Schmitt C, Babin-Boillettot A, Michon J, French Society of Paediatric Oncology.
    Br J Cancer; 2001 Nov 30; 85(11):1646-54. PubMed ID: 11742482
    [Abstract] [Full Text] [Related]

  • 13. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE.
    J Clin Oncol; 2004 Jul 15; 22(14):2873-6. PubMed ID: 15254055
    [Abstract] [Full Text] [Related]

  • 14. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
    Breitfeld PP, Lyden E, Raney RB, Teot LA, Wharam M, Lobe T, Crist WM, Maurer HM, Donaldson SS, Ruymann FB.
    J Pediatr Hematol Oncol; 2001 May 15; 23(4):225-33. PubMed ID: 11846301
    [Abstract] [Full Text] [Related]

  • 15. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS.
    Eur J Cancer; 2005 Mar 15; 41(5):727-34. PubMed ID: 15763649
    [Abstract] [Full Text] [Related]

  • 16. Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology.
    Castex MP, Rubie H, Stevens MC, Escribano CC, de Gauzy JS, Gomez-Brouchet A, Rey A, Delattre O, Oberlin O.
    J Clin Oncol; 2007 Apr 01; 25(10):1176-82. PubMed ID: 17401006
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
    Blakely ML, Andrassy RJ, Raney RB, Anderson JR, Wiener ES, Rodeberg DA, Paidas CN, Lobe TE, Crist WM, Intergroup Rhabdomyosarcoma Studies I through IV.
    J Pediatr Surg; 2003 Mar 01; 38(3):347-53. PubMed ID: 12632347
    [Abstract] [Full Text] [Related]

  • 18. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation.
    Paulino AC, Bauman N, Simon JH, Nguyen TX, Ritchie JM, Tannous R.
    Med Pediatr Oncol; 2003 Aug 01; 41(2):118-22. PubMed ID: 12825215
    [Abstract] [Full Text] [Related]

  • 19. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
    Douglas JG, Arndt CA, Hawkins DS.
    Eur J Cancer; 2007 Apr 01; 43(6):1045-50. PubMed ID: 17368885
    [Abstract] [Full Text] [Related]

  • 20. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
    Spunt SL, Smith LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, Anderson JR, Crist WM, Link MP.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6072-9. PubMed ID: 15447992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.